Global Open-Angle Glaucoma Therapeutics Market Growth (Status and Outlook) 2025-2031

December 2025 | 70 pages | ID: GB7443E5ECA5EN
LP Information

Abstracts

According to this study, the global Open-Angle Glaucoma Therapeutics market size will reach US$ million by 2031.

Glaucoma is a group of eye diseases which result in damage to the optic nerve and cause vision loss.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Open-Angle Glaucoma Therapeutics Industry Forecast” looks at past sales and reviews total world Open-Angle Glaucoma Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Open-Angle Glaucoma Therapeutics sales for 2025 through 2031. With Open-Angle Glaucoma Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Open-Angle Glaucoma Therapeutics industry.

This Insight Report provides a comprehensive analysis of the global Open-Angle Glaucoma Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Open-Angle Glaucoma Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Open-Angle Glaucoma Therapeutics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Open-Angle Glaucoma Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Open-Angle Glaucoma Therapeutics.

This report presents a comprehensive overview, market shares, and growth opportunities of Open-Angle Glaucoma Therapeutics market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Prostaglandin Analogs (PGAs)
• Combination of PGAs
• Other

Segmentation by Application:

• Hospital
• Clinic
• Research Institute
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Aerie Pharmaceuticals Inc.
• Allergan Plc
• Bausch Health Companies, Inc.
• Novartis AG
• Pfizer Inc.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Open-Angle Glaucoma Therapeutics Market Size (2020-2031)
  2.1.2 Open-Angle Glaucoma Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Open-Angle Glaucoma Therapeutics by Country/Region (2020, 2024 & 2031)
2.2 Open-Angle Glaucoma Therapeutics Segment by Type
  2.2.1 Prostaglandin Analogs (PGAs)
  2.2.2 Combination of PGAs
  2.2.3 Other
2.3 Open-Angle Glaucoma Therapeutics Market Size by Type
  2.3.1 Open-Angle Glaucoma Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Open-Angle Glaucoma Therapeutics Market Size Market Share by Type (2020-2025)
2.4 Open-Angle Glaucoma Therapeutics Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Research Institute
  2.4.4 Other
2.5 Open-Angle Glaucoma Therapeutics Market Size by Application
  2.5.1 Open-Angle Glaucoma Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Open-Angle Glaucoma Therapeutics Market Size Market Share by Application (2020-2025)

3 OPEN-ANGLE GLAUCOMA THERAPEUTICS MARKET SIZE BY PLAYER

3.1 Open-Angle Glaucoma Therapeutics Market Size Market Share by Player
  3.1.1 Global Open-Angle Glaucoma Therapeutics Revenue by Player (2020-2025)
  3.1.2 Global Open-Angle Glaucoma Therapeutics Revenue Market Share by Player (2020-2025)
3.2 Global Open-Angle Glaucoma Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 OPEN-ANGLE GLAUCOMA THERAPEUTICS BY REGION

4.1 Open-Angle Glaucoma Therapeutics Market Size by Region (2020-2025)
4.2 Global Open-Angle Glaucoma Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Open-Angle Glaucoma Therapeutics Market Size Growth (2020-2025)
4.4 APAC Open-Angle Glaucoma Therapeutics Market Size Growth (2020-2025)
4.5 Europe Open-Angle Glaucoma Therapeutics Market Size Growth (2020-2025)
4.6 Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Open-Angle Glaucoma Therapeutics Market Size by Country (2020-2025)
5.2 Americas Open-Angle Glaucoma Therapeutics Market Size by Type (2020-2025)
5.3 Americas Open-Angle Glaucoma Therapeutics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Open-Angle Glaucoma Therapeutics Market Size by Region (2020-2025)
6.2 APAC Open-Angle Glaucoma Therapeutics Market Size by Type (2020-2025)
6.3 APAC Open-Angle Glaucoma Therapeutics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Open-Angle Glaucoma Therapeutics Market Size by Country (2020-2025)
7.2 Europe Open-Angle Glaucoma Therapeutics Market Size by Type (2020-2025)
7.3 Europe Open-Angle Glaucoma Therapeutics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Open-Angle Glaucoma Therapeutics by Region (2020-2025)
8.2 Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size by Type (2020-2025)
8.3 Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL OPEN-ANGLE GLAUCOMA THERAPEUTICS MARKET FORECAST

10.1 Global Open-Angle Glaucoma Therapeutics Forecast by Region (2026-2031)
  10.1.1 Global Open-Angle Glaucoma Therapeutics Forecast by Region (2026-2031)
  10.1.2 Americas Open-Angle Glaucoma Therapeutics Forecast
  10.1.3 APAC Open-Angle Glaucoma Therapeutics Forecast
  10.1.4 Europe Open-Angle Glaucoma Therapeutics Forecast
  10.1.5 Middle East & Africa Open-Angle Glaucoma Therapeutics Forecast
10.2 Americas Open-Angle Glaucoma Therapeutics Forecast by Country (2026-2031)
  10.2.1 United States Market Open-Angle Glaucoma Therapeutics Forecast
  10.2.2 Canada Market Open-Angle Glaucoma Therapeutics Forecast
  10.2.3 Mexico Market Open-Angle Glaucoma Therapeutics Forecast
  10.2.4 Brazil Market Open-Angle Glaucoma Therapeutics Forecast
10.3 APAC Open-Angle Glaucoma Therapeutics Forecast by Region (2026-2031)
  10.3.1 China Open-Angle Glaucoma Therapeutics Market Forecast
  10.3.2 Japan Market Open-Angle Glaucoma Therapeutics Forecast
  10.3.3 Korea Market Open-Angle Glaucoma Therapeutics Forecast
  10.3.4 Southeast Asia Market Open-Angle Glaucoma Therapeutics Forecast
  10.3.5 India Market Open-Angle Glaucoma Therapeutics Forecast
  10.3.6 Australia Market Open-Angle Glaucoma Therapeutics Forecast
10.4 Europe Open-Angle Glaucoma Therapeutics Forecast by Country (2026-2031)
  10.4.1 Germany Market Open-Angle Glaucoma Therapeutics Forecast
  10.4.2 France Market Open-Angle Glaucoma Therapeutics Forecast
  10.4.3 UK Market Open-Angle Glaucoma Therapeutics Forecast
  10.4.4 Italy Market Open-Angle Glaucoma Therapeutics Forecast
  10.4.5 Russia Market Open-Angle Glaucoma Therapeutics Forecast
10.5 Middle East & Africa Open-Angle Glaucoma Therapeutics Forecast by Region (2026-2031)
  10.5.1 Egypt Market Open-Angle Glaucoma Therapeutics Forecast
  10.5.2 South Africa Market Open-Angle Glaucoma Therapeutics Forecast
  10.5.3 Israel Market Open-Angle Glaucoma Therapeutics Forecast
  10.5.4 Turkey Market Open-Angle Glaucoma Therapeutics Forecast
10.6 Global Open-Angle Glaucoma Therapeutics Forecast by Type (2026-2031)
10.7 Global Open-Angle Glaucoma Therapeutics Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Open-Angle Glaucoma Therapeutics Forecast

11 KEY PLAYERS ANALYSIS

11.1 Aerie Pharmaceuticals Inc.
  11.1.1 Aerie Pharmaceuticals Inc. Company Information
  11.1.2 Aerie Pharmaceuticals Inc. Open-Angle Glaucoma Therapeutics Product Offered
  11.1.3 Aerie Pharmaceuticals Inc. Open-Angle Glaucoma Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Aerie Pharmaceuticals Inc. Main Business Overview
  11.1.5 Aerie Pharmaceuticals Inc. Latest Developments
11.2 Allergan Plc
  11.2.1 Allergan Plc Company Information
  11.2.2 Allergan Plc Open-Angle Glaucoma Therapeutics Product Offered
  11.2.3 Allergan Plc Open-Angle Glaucoma Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Allergan Plc Main Business Overview
  11.2.5 Allergan Plc Latest Developments
11.3 Bausch Health Companies, Inc.
  11.3.1 Bausch Health Companies, Inc. Company Information
  11.3.2 Bausch Health Companies, Inc. Open-Angle Glaucoma Therapeutics Product Offered
  11.3.3 Bausch Health Companies, Inc. Open-Angle Glaucoma Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Bausch Health Companies, Inc. Main Business Overview
  11.3.5 Bausch Health Companies, Inc. Latest Developments
11.4 Novartis AG
  11.4.1 Novartis AG Company Information
  11.4.2 Novartis AG Open-Angle Glaucoma Therapeutics Product Offered
  11.4.3 Novartis AG Open-Angle Glaucoma Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Novartis AG Main Business Overview
  11.4.5 Novartis AG Latest Developments
11.5 Pfizer Inc.
  11.5.1 Pfizer Inc. Company Information
  11.5.2 Pfizer Inc. Open-Angle Glaucoma Therapeutics Product Offered
  11.5.3 Pfizer Inc. Open-Angle Glaucoma Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Pfizer Inc. Main Business Overview
  11.5.5 Pfizer Inc. Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Open-Angle Glaucoma Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Open-Angle Glaucoma Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Prostaglandin Analogs (PGAs)
Table 4. Major Players of Combination of PGAs
Table 5. Major Players of Other
Table 6. Open-Angle Glaucoma Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Open-Angle Glaucoma Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Open-Angle Glaucoma Therapeutics Market Size Market Share by Type (2020-2025)
Table 9. Open-Angle Glaucoma Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Open-Angle Glaucoma Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Open-Angle Glaucoma Therapeutics Market Size Market Share by Application (2020-2025)
Table 12. Global Open-Angle Glaucoma Therapeutics Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Open-Angle Glaucoma Therapeutics Revenue Market Share by Player (2020-2025)
Table 14. Open-Angle Glaucoma Therapeutics Key Players Head office and Products Offered
Table 15. Open-Angle Glaucoma Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Open-Angle Glaucoma Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Open-Angle Glaucoma Therapeutics Market Size Market Share by Region (2020-2025)
Table 20. Global Open-Angle Glaucoma Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Open-Angle Glaucoma Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Open-Angle Glaucoma Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Open-Angle Glaucoma Therapeutics Market Size Market Share by Country (2020-2025)
Table 24. Americas Open-Angle Glaucoma Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Open-Angle Glaucoma Therapeutics Market Size Market Share by Type (2020-2025)
Table 26. Americas Open-Angle Glaucoma Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Open-Angle Glaucoma Therapeutics Market Size Market Share by Application (2020-2025)
Table 28. APAC Open-Angle Glaucoma Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Open-Angle Glaucoma Therapeutics Market Size Market Share by Region (2020-2025)
Table 30. APAC Open-Angle Glaucoma Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Open-Angle Glaucoma Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Open-Angle Glaucoma Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Open-Angle Glaucoma Therapeutics Market Size Market Share by Country (2020-2025)
Table 34. Europe Open-Angle Glaucoma Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Open-Angle Glaucoma Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Open-Angle Glaucoma Therapeutics
Table 40. Key Market Challenges & Risks of Open-Angle Glaucoma Therapeutics
Table 41. Key Industry Trends of Open-Angle Glaucoma Therapeutics
Table 42. Global Open-Angle Glaucoma Therapeutics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Open-Angle Glaucoma Therapeutics Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Open-Angle Glaucoma Therapeutics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Open-Angle Glaucoma Therapeutics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Aerie Pharmaceuticals Inc. Details, Company Type, Open-Angle Glaucoma Therapeutics Area Served and Its Competitors
Table 47. Aerie Pharmaceuticals Inc. Open-Angle Glaucoma Therapeutics Product Offered
Table 48. Aerie Pharmaceuticals Inc. Open-Angle Glaucoma Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Aerie Pharmaceuticals Inc. Main Business
Table 50. Aerie Pharmaceuticals Inc. Latest Developments
Table 51. Allergan Plc Details, Company Type, Open-Angle Glaucoma Therapeutics Area Served and Its Competitors
Table 52. Allergan Plc Open-Angle Glaucoma Therapeutics Product Offered
Table 53. Allergan Plc Open-Angle Glaucoma Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Allergan Plc Main Business
Table 55. Allergan Plc Latest Developments
Table 56. Bausch Health Companies, Inc. Details, Company Type, Open-Angle Glaucoma Therapeutics Area Served and Its Competitors
Table 57. Bausch Health Companies, Inc. Open-Angle Glaucoma Therapeutics Product Offered
Table 58. Bausch Health Companies, Inc. Open-Angle Glaucoma Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Bausch Health Companies, Inc. Main Business
Table 60. Bausch Health Companies, Inc. Latest Developments
Table 61. Novartis AG Details, Company Type, Open-Angle Glaucoma Therapeutics Area Served and Its Competitors
Table 62. Novartis AG Open-Angle Glaucoma Therapeutics Product Offered
Table 63. Novartis AG Open-Angle Glaucoma Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Novartis AG Main Business
Table 65. Novartis AG Latest Developments
Table 66. Pfizer Inc. Details, Company Type, Open-Angle Glaucoma Therapeutics Area Served and Its Competitors
Table 67. Pfizer Inc. Open-Angle Glaucoma Therapeutics Product Offered
Table 68. Pfizer Inc. Open-Angle Glaucoma Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Pfizer Inc. Main Business
Table 70. Pfizer Inc. Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Open-Angle Glaucoma Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Open-Angle Glaucoma Therapeutics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Open-Angle Glaucoma Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Open-Angle Glaucoma Therapeutics Sales Market Share by Country/Region (2024)
Figure 8. Open-Angle Glaucoma Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Open-Angle Glaucoma Therapeutics Market Size Market Share by Type in 2024
Figure 10. Open-Angle Glaucoma Therapeutics in Hospital
Figure 11. Global Open-Angle Glaucoma Therapeutics Market: Hospital (2020-2025) & ($ millions)
Figure 12. Open-Angle Glaucoma Therapeutics in Clinic
Figure 13. Global Open-Angle Glaucoma Therapeutics Market: Clinic (2020-2025) & ($ millions)
Figure 14. Open-Angle Glaucoma Therapeutics in Research Institute
Figure 15. Global Open-Angle Glaucoma Therapeutics Market: Research Institute (2020-2025) & ($ millions)
Figure 16. Open-Angle Glaucoma Therapeutics in Other
Figure 17. Global Open-Angle Glaucoma Therapeutics Market: Other (2020-2025) & ($ millions)
Figure 18. Global Open-Angle Glaucoma Therapeutics Market Size Market Share by Application in 2024
Figure 19. Global Open-Angle Glaucoma Therapeutics Revenue Market Share by Player in 2024
Figure 20. Global Open-Angle Glaucoma Therapeutics Market Size Market Share by Region (2020-2025)
Figure 21. Americas Open-Angle Glaucoma Therapeutics Market Size 2020-2025 ($ millions)
Figure 22. APAC Open-Angle Glaucoma Therapeutics Market Size 2020-2025 ($ millions)
Figure 23. Europe Open-Angle Glaucoma Therapeutics Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size 2020-2025 ($ millions)
Figure 25. Americas Open-Angle Glaucoma Therapeutics Value Market Share by Country in 2024
Figure 26. United States Open-Angle Glaucoma Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Open-Angle Glaucoma Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Open-Angle Glaucoma Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Open-Angle Glaucoma Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Open-Angle Glaucoma Therapeutics Market Size Market Share by Region in 2024
Figure 31. APAC Open-Angle Glaucoma Therapeutics Market Size Market Share by Type (2020-2025)
Figure 32. APAC Open-Angle Glaucoma Therapeutics Market Size Market Share by Application (2020-2025)
Figure 33. China Open-Angle Glaucoma Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Open-Angle Glaucoma Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Open-Angle Glaucoma Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Open-Angle Glaucoma Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 37. India Open-Angle Glaucoma Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Open-Angle Glaucoma Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Open-Angle Glaucoma Therapeutics Market Size Market Share by Country in 2024
Figure 40. Europe Open-Angle Glaucoma Therapeutics Market Size Market Share by Type (2020-2025)
Figure 41. Europe Open-Angle Glaucoma Therapeutics Market Size Market Share by Application (2020-2025)
Figure 42. Germany Open-Angle Glaucoma Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 43. France Open-Angle Glaucoma Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Open-Angle Glaucoma Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Open-Angle Glaucoma Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Open-Angle Glaucoma Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Open-Angle Glaucoma Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Open-Angle Glaucoma Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Open-Angle Glaucoma Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Open-Angle Glaucoma Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Open-Angle Glaucoma Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Open-Angle Glaucoma Therapeutics Market Size 2026-2031 ($ millions)
Figure 56. APAC Open-Angle Glaucoma Therapeutics Market Size 2026-2031 ($ millions)
Figure 57. Europe Open-Angle Glaucoma Therapeutics Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size 2026-2031 ($ millions)
Figure 59. United States Open-Angle Glaucoma Therapeutics Market Size 2026-2031 ($ millions)
Figure 60. Canada Open-Angle Glaucoma Therapeutics Market Size 2026-2031 ($ millions)
Figure 61. Mexico Open-Angle Glaucoma Therapeutics Market Size 2026-2031 ($ millions)
Figure 62. Brazil Open-Angle Glaucoma Therapeutics Market Size 2026-2031 ($ millions)
Figure 63. China Open-Angle Glaucoma Therapeutics Market Size 2026-2031 ($ millions)
Figure 64. Japan Open-Angle Glaucoma Therapeutics Market Size 2026-2031 ($ millions)
Figure 65. Korea Open-Angle Glaucoma Therapeutics Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Open-Angle Glaucoma Therapeutics Market Size 2026-2031 ($ millions)
Figure 67. India Open-Angle Glaucoma Therapeutics Market Size 2026-2031 ($ millions)
Figure 68. Australia Open-Angle Glaucoma Therapeutics Market Size 2026-2031 ($ millions)
Figure 69. Germany Open-Angle Glaucoma Therapeutics Market Size 2026-2031 ($ millions)
Figure 70. France Open-Angle Glaucoma Therapeutics Market Size 2026-2031 ($ millions)
Figure 71. UK Open-Angle Glaucoma Therapeutics Market Size 2026-2031 ($ millions)
Figure 72. Italy Open-Angle Glaucoma Therapeutics Market Size 2026-2031 ($ millions)
Figure 73. Russia Open-Angle Glaucoma Therapeutics Market Size 2026-2031 ($ millions)
Figure 74. Egypt Open-Angle Glaucoma Therapeutics Market Size 2026-2031 ($ millions)
Figure 75. South Africa Open-Angle Glaucoma Therapeutics Market Size 2026-2031 ($ millions)
Figure 76. Israel Open-Angle Glaucoma Therapeutics Market Size 2026-2031 ($ millions)
Figure 77. Turkey Open-Angle Glaucoma Therapeutics Market Size 2026-2031 ($ millions)
Figure 78. Global Open-Angle Glaucoma Therapeutics Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Open-Angle Glaucoma Therapeutics Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Open-Angle Glaucoma Therapeutics Market Size 2026-2031 ($ millions)